ISCOMs vaccine against experimental leishmaniasis

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 885-892

  Papadopoulou, Georgia ^a   Karagouni, Evdokia ^a   Dotsika, Eleni ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

gp63; ISCOMs; Leishmania

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN 63; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; ISCOM; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; ISCOMS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0032078696     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00308-3     Document Type: Article

References (72)

1. 1 Muller, I., Garcia-Sanz, J.A., Titus, R., Behin, R. and Louis, J. Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite Leishmania major, Immunol. Rev. 1989, 112, 95-113.
2. 2 World Health Organization The leishmaniasis. Tec. Rep. Ser. 1984, 701, 1-140.
3. 3 Liew, F.Y. Cell mediated immunity in experimental cutaneous leishmaniasis. Parasitol. Today 1986, 2, 264-270.
4. 4 Mitchell, G.F., Handman, E. and Spithill, T.W. et al. Resistance and susceptibility of mice to Leishmania major: a view from Melbourne. Ann. Inst. Pasteur Immunol. 1987, 138, 738-743.
5. 5 Louis, J., Pedrazini, T. and Titus, R.G. et al. Immunobiology of experimental leishmaniasis. Ann. Inst. Pasteur Immunol. 1987, 138, 755-758.
6. 6 Moddaber, F. Experience with vaccines against cutaneous leishmaniasis: of men and mice. Parasitology 1989, 98, S49-S60.
7. 7 Scott, P. The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis. Exp. Parasitol. 1989, 68, 369-372.
8. 8 Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L. and Locksley, R.M. Reciprocal expression of interferon-gamma and interleukin-4 during the resolution of progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 1989, 169, 59.
9. 9 Handman, E., Symons, F.M., Baldwin, T.M., Curtis, J.M. and Scheerlinck, J. P. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response. Infect. Immun. 1995, 63, 4261-4267.
10. 10 Jaffe, C.L., Rachamim, N. and Sarfstein, R. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. J. Immunol. 1990, 144, 699-706.
11. 11 Handman, E. and Goding, J.W. The Leishmania receptor for macrophages is a lipid containing glycoconjugate. EMBO J. 1985, 4, 329-336.
12. 12 Puentes, S.M., Sacks, D.L., Da Slilva, R.P. and Joiner, K.A. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J. Exp. Med. 1988, 167, 887-902.
13. 13 Russel, D.G. The macrophage attachment glycoprotein gp63 in the predominant C3-acceptor site on Leishmania mexicana promastigotes. Eur. J. Biochem. 1987, 164, 213-221.
14. 14 Russel, D.G. and Wilhelm, H. The involvment of the major surface gkycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. J. Immunol. 1986, 136, 2613-2620.
15. 15 Russel, D.G. and Write, S.D. Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes. J. Exp. Med. 1988, 168, 279-292.
16. 16 Handman, E. and Mitschell, G.F. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl Acad. Sci. USA 1985, 82, 5910-5914.
17. 17 Russo, D.M., Burns, J.M. and Carvalho, E.M. et al. Human T cell responses to gp63, a surface antigen of Leishmania. J. Immunol. 1991, 147, 3575-3580.
18. 18 Handman, E., Button, L.L. and McMaster, R.W. Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice. Exp. Parasitol. 1990, 70, 427-435.
19. 19 Yang, D.M., Fairweather, N., Button, L.L., McMaster, W.R., Kahl, L.P. and Liew, F.W. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmania surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 1990, 145, 2281-2285.
20. 20 Russel, D.G. and Alexander, J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 1988, 140, 1274-1279.
21. 21 Morein, B., Sundquist, B., Hoglund, S., Dalsgaard, K. and Osterhaus, A. ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 1984, 308, 457-460.
22. 22 Morein, B. The ISCOM antigen-presenting system. Nature 1988, 332, 287-288.
23. 23 Morein, B., Lovgren, K., Ronnberg, B., Sjolander, A. and Villacres-Eriksson, M. Immunostimulating complexes: clinical potential in vaccine development Clin. Immunother. 1995, 3, 461-475.
24. 24 Browning, M., Reid, G., Osborne, R. and Jarrett, O. Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies. Vaccine 1992, 10, 585-590.
25. 25 Osterhaus, A., de Vries, P., Morein, B., Akerblom, L. and Heeney, J. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge. AIDS Res. Hum. Retroviruses 1992, 8, 1507-1510.
26. 26 Morgan, A.J., Finerty, S., Lovgren, K., Scullion, F.T. and Morein, B. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes. J. Gen. Virol. 1988, 69, 2093-2096.
27. 27 Dotsika, E., Karagouni, E., Sandquist, B., Morein, B., Morgan, A. and Villacress-Ertksson, M. Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Bar virus ISCOMs. Scand. J. Immunol. 1997, 45, 261-268.
28. 28 Lovgren, K., Kaberg, H. and Morein, B. An experimental influenza subunit vaccine. (ISCOM)-induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration. Clin. Exp. Immunol. 1990, 82, 435-439.
29. 29 de Vries, P., van Binnendijk, R.S. and van der Marek, P. et al. Measles virus fusion protein presented in an immune-stimulating complex (ISCOM) induces haemolysis-inhibiting and fusion inhibiting antibodies, virus specific T cells and protection in mice. J. Gen. Virol. 1988, 69, 549-559.
30. 30 Tarpey, I., Stacey, S.N., McIndoe, A. and Davies, H. Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs). Vaccine 1996, 14, 230-236.
31. 31 Buxton, D., Uggla, A. and Lovgren, K. et al. Trial of a novel experimental Toxoplasma ISCOM vaccine in pregnant sheep. Br. Vet. J. 1989, 145, 451-457.
32. 32 Lunden, A., Lovgren, K., Uggla, A. and Araujo, F. Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes. Infect. Immun. 1993, 61, 2639-2643.
33. 33 Uggla, A., Araujo, F.G., Lunden, A., Lovgren, K., Reminton, J.S. and Morein, B. Immunising effects in mice of two Toxoplasma gondii ISCOM preparations. J. Vet. Med. 1988, B35, 311-314.
34. 34 Overnes, G., Nesse, L.L., Waldeland, H., Lovgren, K. and Gudding, R. Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccine. Vaccine 1991, 9, 23-28.
35. 35 Kazanjii, M., Laurent, F. and Perry, P. Immune responses and protective effect in mice vaccinated with surface sporozoite protein of Eimeria falciformis in ISCOMs. Vaccine 1994, 12, 798-804.
36. 36 Sjolander, A., Hansson, M., Lovgren, K., Wahlin, B., Berzins, K. and Perlmann, P. Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of Plasmodium falciparum antigen Pf155/RESA. Parasite Immunol. 1993, 15, 355-359.
37. 37 Sjolander, A., Lovgren, K. and Stahl, S. et al. High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of Plasmodium falciparum antigen Pf155/RESA. Vaccine 1991, 9, 443-450.
38. 38 Jakobsen, P.M., Hviid, L. and Theander, T.G. et al. Isolation and characterization of a soluble antigen complex of Plasmodium falciparum with pyrogenic properties. Apmis. 1991, 99, 21-29.
39. 39 Lockyer, M.J., Cooper, H., Tite, J., Powan, W. and Crowe, J.S. Immunogenicity of hybrid Plasmodium falciparum malaria antigen. Parasitology 1993, 106, 451-457.
40. 40 Sjolander, A., Stahl, S. and Lovgren, K. et al. Plasmodium falciparum: the immune response in rabbits to the clustered aspargine-rich protein (CARP) after immunization in Freud's adjuvant or immunostimulating complexes (ISCOMs). Exp. Parasitol. 1993, 76, 134-145.
41. 41 Araujo, F.G. and Morein, B. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into ISCOMs protects against lethal challenge in mice. Inf. Immun. 1991, 59, 2909-2914.
42. 42 Bouvier, J., Etges, R.J. and Bordier, C. Identification and purification of membrane and soluble forms of the major surface protease in seven species of Leishmania promastigotes. J. Biol. Chem. 1985, 260, 15504-15509.
43. 43 Bouvier, J., Bordier, C., Vogel, H., Reichelt, R. and Etges, R. Characterization of the promastigote surface protease of Leishmania as a membrane-bound zinc endopeptidase. Molec. Biochem. Parasitol. 1989, 37, 235-246.
44. 44 Sundquist, B., Lovgren, K., Hoglund, S. and Morein, B. Influenza virus ISCOMs: biochemical characterization. Vaccine 1988, 6, 44-48.
45. 45 Villacress-Eriksson, M., Kaberg, H., Mollaoglu, M. and Morein, B. Involvment of interleukin-2 and interferon-gamma in the immune response induced by influenza virus ISCOMs. Scand. J. Immunol. 1992, 36, 421-426.
46. 46 Kahl, L.P., Lelchuk, R., Scott, C.A. and Beesley, J. Characterization of Leishmania major antigen-liposomes that protect Balb/c mice against cutaneous leishmaniasis. Inf. Immun. 1990, 58, 3233-3241.
47. 47 Bogdan, C., Schroppel, K., Lohoff, M., Rollinghoff, M. and Solbach, W. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells. Eur. J. Immunol. 1990, 20, 2533-2540.
48. 48 Scott, P., Pearce, E., Natovitz, P. and Sher, A. Vaccination against cutaneous leishmaniasis in a murine model: I. Induction of protective immunity with a soluble antigen extract of promastigotes. J. Immunol. 1987, 1, 221-227.
49. 49 Bretscher, P., Wei, G., Menon, J. and Bielefeld-Ohmann, H. Establishment of stable, cell-mediated immunity that makes susceptible mice resistant to Leishmania major. Science 1992, 257, 539-542.
50. 50 Menon, J. and Bretscher, P. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistence to a normally pathogenic challenge. Eur. J. Immunol. 1996, 26, 243-249.
51. 51 Dalton, D.K., Pitts-Meek, S., Keshav, S., Figari, I.S., Bradley, A. and Stewart, T.A. Multiple defects of immune cell funvtion in mice with disrupted interferon-γ genes. Science 1993, 259, 1739-1742.
52. 52 Pond, L., Wasson, D.L. and Hayes, C.E. Evidence for differential induction of helper T cell subsets during Trichinella spiralis infection. J. Immunol. 1989, 143, 4232-4237.
53. 53 Haralabidis, S., Karagouni, E., Frydas, S. and Dotsika, E. Immunoglobulin and cytokine profile in murine secondary hydatidoses. Parasite Immunol. 1995, 17, 625-630.
54. 54 Malloy, K.J., Donachie, A.M. and Mowat, A.M. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMs. Eur. J. Immunol. 1995, 25, 2835-2841.
55. 55 Malloy, K.J., Donachie, A.M., O'Hagan, D.T. and Mowat, A.M. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly (lactide-co-glycolide) microparticles. Immunology 1994, 81, 661-667.
56. 56 Mowat, A.M. and Donachie, A.M. ISCOMs - a novel strategy for mucosal immunization?. Immunol. Today 1991, 12, 383-385.
57. 57 Karagouni, E.E. and Hajipetrou-Kourounakis, L. Regulation of isotype immunoglobulin production by adjuvants in vivo. Scand. J. Immunol. 1990, 31, 745-754.
58. 58 Valensi, J.P., Carlson, J.R. and Van Nest, GA Systemic cytokine profiles in Balb/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 1994, 153, 4029-4039.
59. 59 Villacres-Eriksson, M., Bergstrom-Mollaoglu, M., Kaberg, H. and Morein, B. Involvment of interleukin-2 and interferon-gamma in the immune response induced by influenza virus ISCOMs. Scand. J. Immunol. 1992, 36, 421-426.
60. 60 Villacres-Eriksson, M. Antigen presentation by naïve macrophages, dendritic cells and B cells primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin. Exp. Immunol. 1995, 102, 46-52.
61. 61 Bergstrom-Mollaoglu, M., Lovgren, K., Ajerblom, L., Fossum, S. and Morein, B. Antigen-specific increases in the number of spleenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms. Scand. J. Immunol. 1992, 36, 567-574.
62. 62 Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N. and Berzofski, J.A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 1990, 344, 873-875.
63. 63 Zugel, U., Schoel, B., Yamamoto, S., Hengel, H., Morein, B. and Kaufmann, S.H.E. Crossrecognition by CD8+T cell receptor αβ cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur. J. Immunol. 1995, 25, 451-458.
64. 64 Bendelac, A. and Schwartz, R.H. CD4+ and CD8+ T cells aquire specific lymphokine secretion potentials during thymic maturation. Nature 1991, 353, 68-70.
65. 65 Mosmann, T.R. and Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996, 17, 138-146.
66. 66 Lovgren-Bengtsson, K. and Sjolander, A. Adjuvant activity of ISCOMs - effect of ratio and incorporation of antigen and adjuvants. Vaccine 1996, 14, 753-759.
67. 67 Xu, D. and Liew, F.Y. Protection against leishmaniasis by infection of DNA encoding a major surface glycoprotein gp63 of L. major, Immunol. 1995, 84, 173-176.
68. 68 Howard, M. and O'Garra, A. Biological properties of interleukin 10. Immunol. Today 1992, 13, 198-200.
69. 69 Chang, C.S. and Chang, K.P. Monoclonal antibody affinity purification of Leishmania membrane glycoprotein and its inhibition of Leishmania-macrophage binding. Proc. Natl Acad. Sci. USA 1986, 83, 100-104.
70. 70 Dhaliwal, J.S., Liew, F.Y. and Cox, F.E.G. Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis. Inf. Immun. 1985, 49, 417-423.
71. 71 Liew, F.Y. Functional heterogeneity of CD4+T cells in leishmaniasis. Immunol. Today 1989, 10, 40-45.
72. 72 Mosmann, T.R. and Coffman, R.L. Two types of mouse helper T cell clone, Immunol. Today 1987, 8, 223-227.